Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurology Clinic, PC
mi
from
Cordova, TN
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurology Clinic, PC
mi
from
Cordova, TN
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
NeuroStudies.net
mi
from
Decatur, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
NeuroStudies.net
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
NoesisPharma Clinical Trials
mi
from
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
NoesisPharma Clinical Trials
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Oklahoma Clinical Research Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Olive Branch Family Medical
mi
from
Olive Branch, MS
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Olive Branch Family Medical
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Pacific Research Network
mi
from
San Diego, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Pacific Research Network
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Premiere Research Institute at Palm Beach Neurology
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
QUEST Research Institute
mi
from
Farmington Hills, MI
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
QUEST Research Institute
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Research Center for Clinical Studies, Inc.
mi
from
Norwalk, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Research Foundation for Mental Hygiene, Inc.
mi
from
Orangeburg, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Research Foundation for Mental Hygiene, Inc.
mi
from
Orangeburg, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
RI Hospital
mi
from
Providence, RI
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
RI Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Ruan Neurology Clinic and Research Center
mi
from
Des Moines, IA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Ruan Neurology Clinic and Research Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Schuster Medical Research Institute
mi
from
Sherman Oaks, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Schuster Medical Research Institute
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Senior Adults Specialty Research
mi
from
Austin, TX
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Senior Adults Specialty Research
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Southern California Research, LLC
mi
from
Fountain Valley, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Southern California Research, LLC
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Roskamp Institute
mi
from
Sarasota, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Roskamp Institute
mi
from
Sarasota, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
USF Health Byrd Alzheimer's Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Wake Research Associates, LLC
mi
from
Raleigh, NC
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Xenoscience, Inc / 21st Century Neurology
mi
from
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Xenoscience, Inc / 21st Century Neurology
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CITrials, Inc.
mi
from
Bellflower, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CITrials, Inc.
mi
from
Bellflower, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Synergy East
mi
from
Lemon Grove, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Synergy East
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research, LLC - North Clinic
mi
from
The Villages, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research, LLC - North Clinic
mi
from
The Villages, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
PRA Health Sciences
mi
from
Salt Lake City, UT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
PRA Health Sciences
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Discipline of Psychiatry, University of Queensland
mi
from
Herston,
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 18-Month Safety and Efficacy Study of TRx0237 in Subjects With Mild Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Discipline of Psychiatry, University of Queensland
mi
from
Herston,
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Xenoscience, Inc / 21st Century Neurology
mi
from
Phoenix, AZ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Xenoscience, Inc / 21st Century Neurology
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Feldman, Robert MD
mi
from
Laguna Hills, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Feldman, Robert MD
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
University of Southern California
mi
from
Los Angeles, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Pacific Research Network
mi
from
San Diego, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Pacific Research Network
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Yale University School of Medicine
mi
from
New Haven, CT
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
JEM Research, LLC
mi
from
Atlantis, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
JEM Research, LLC
mi
from
Atlantis, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Brain Matters Research
mi
from
Delray Beach, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Brain Matters Research
mi
from
Delray Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CNS Healthcare, Inc
mi
from
Jacksonville, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CNS Healthcare, Inc
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research, LLC: North Clinic
mi
from
Leesburg, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research, LLC: North Clinic
mi
from
Leesburg, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Miami Research Associates
mi
from
Miami, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Miami Research Associates
mi
from
Miami, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
iResearch Atlanta LLC
mi
from
Decatur, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Alexian Brothers Neurosciences Institute
mi
from
Elk Grove, IL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Alexian Brothers Neurosciences Institute
mi
from
Elk Grove, IL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
ActivMed Practices & Research
mi
from
Methuen, MA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
ActivMed Practices & Research
mi
from
Methuen, MA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Olive Branch Family Medical
mi
from
Olive Branch, MS
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Olive Branch Family Medical
mi
from
Olive Branch, MS
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Memory Enhancement Centers of America, Inc
mi
from
Eatontown, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Memory Enhancement Centers of America, Inc
mi
from
Eatontown, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
CRI Worldwide
mi
from
Marlton, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
CRI Worldwide
mi
from
Marlton, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Advanced Memory Research Institute of NJ PC
mi
from
Toms River, NJ
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Advanced Memory Research Institute of NJ PC
mi
from
Toms River, NJ
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurological Associates of Albany, P. C.
mi
from
Albany, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurological Associates of Albany, P. C.
mi
from
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
SPRI
mi
from
Brooklyn, NY
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
SPRI
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
Neurobehavioral Clinical Research
mi
from
Canton, OH
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
Neurobehavioral Clinical Research
mi
from
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
The Clinical Trial Center, LLC
mi
from
Jenkintown, PA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  3/12/2018
FutureSearch Trials of Neurology
mi
from
Austin, TX
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 15-Month Trial of TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 3/12/2018
FutureSearch Trials of Neurology
mi
from
Austin, TX
Click here to add this to my saved trials